FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2183251815> ?p ?o ?g. }

• W2183251815 endingPage "362" @default.
• W2183251815 startingPage "351" @default.
• W2183251815 abstract "Oral anticoagulant (OA) medication is the recommended therapy for reducing the risk of thromboembolic complications in patients with atrial fibrillation (AF), and warfarin is the medication most frequently used. However, nonadherence associated with OA medications may lead to considerable health risks. A conceptual model of OA medication adherence in patients with AF could clarify factors affecting adherence, thereby assisting in the development and structuring of adherence-promotion programs. To our knowledge, such a model, driven by information obtained directly from patients, has never been developed.To develop a conceptual model of adherence to OA medication based on a literature review and patient feedback via qualitative research among patients with AF.A literature search was conducted of English-language articles published between the years 2005 and 2010 that related to factors affecting OA medication adherence, excluding articles pertaining to AF associated with mechanical heart valve replacement. To expand on the literature review findings, 4 focus groups totaling 38 participants aged 60 years or older, diagnosed with nonvalvular AF, and currently taking any OA medication were conducted in 2011. Participants completed the Modified Morisky Scale (MMS), with subscales measuring motivation and knowledge, and were asked about daily processes and behaviors related to taking OA medication. The identification of focus group themes was based on the frequency of participant report and endorsement; themes were spontaneously mentioned or supported by at least 2 people in each of at least 3 focus groups. Model concepts, based on focus group themes and factors identified in the literature review, were determined by the consensus of 3 authors.181 publications were identified; 30 were selected for full-text review. The focus group participants had a mean age of 69.9 years. Most participants reported a diagnosis of hypertension (86.8%, n=33), high cholesterol (50.0%, n=19), heart disease or chronic heart failure (31.6%, n=12), or diabetes (28.9%, n=11). Most (89.5%, n=34) were taking warfarin. About one-half (52.6%, n=20) had been taking an OA medication for less than 5 years. On the MMS, 78.9% of participants reported high levels of motivation, and 100% reported high levels of knowledge. Four concepts emerged from the focus groups and were supported by the literature for inclusion in the model: (a) knowledge base of the disease and continued reinforcement (i.e., health care professional reinforcement); (b) short-term and long-term motivation (e.g., avoidance of negative health consequences); (c) personalized system, habit formation, and system adaptation (e.g., developing a routine or external reminders); and (d) self-efficacy loop (i.e., the personalized system and its adaptability are reinforced as patients become more consistent, confident, and adherent). The literature review also suggested other factors that may also affect patient adherence (e.g., demographic, psychosocial, cognitive).Adherence in patients with AF is complex and involves multiple factors, some specific to each individual and others more general. This model identifies an adherence process that can guide opportunities for effective interventions, such as educational and behavioral programs targeted at these processes, to improve patient adherence to OA medication." @default.
• W2183251815 created "2016-06-24" @default.
• W2183251815 creator A5002110010 @default.
• W2183251815 creator A5021431857 @default.
• W2183251815 creator A5043410223 @default.
• W2183251815 creator A5050134509 @default.
• W2183251815 creator A5052118706 @default.
• W2183251815 creator A5086321001 @default.
• W2183251815 date "2012-06-01" @default.
• W2183251815 modified "2023-09-25" @default.
• W2183251815 title "Development of a Conceptual Model of Adherence to Oral Anticoagulants to Reduce Risk of Stroke in Patients with Atrial Fibrillation" @default.
• W2183251815 cites W1510395108 @default.
• W2183251815 cites W1568955415 @default.
• W2183251815 cites W2056473894 @default.
• W2183251815 cites W2066267661 @default.
• W2183251815 cites W2074334843 @default.
• W2183251815 cites W2109780115 @default.
• W2183251815 cites W2114775432 @default.
• W2183251815 cites W2139662446 @default.
• W2183251815 cites W2153326621 @default.
• W2183251815 doi "https://doi.org/10.18553/jmcp.2012.18.5.351" @default.
• W2183251815 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22663168" @default.
• W2183251815 hasPublicationYear "2012" @default.
• W2183251815 type Work @default.
• W2183251815 sameAs 2183251815 @default.
• W2183251815 citedByCount "40" @default.
• W2183251815 countsByYear W21832518152012 @default.
• W2183251815 countsByYear W21832518152013 @default.
• W2183251815 countsByYear W21832518152014 @default.
• W2183251815 countsByYear W21832518152015 @default.
• W2183251815 countsByYear W21832518152016 @default.
• W2183251815 countsByYear W21832518152017 @default.
• W2183251815 countsByYear W21832518152018 @default.
• W2183251815 countsByYear W21832518152019 @default.
• W2183251815 countsByYear W21832518152020 @default.
• W2183251815 countsByYear W21832518152021 @default.
• W2183251815 countsByYear W21832518152023 @default.
• W2183251815 crossrefType "journal-article" @default.
• W2183251815 hasAuthorship W2183251815A5002110010 @default.
• W2183251815 hasAuthorship W2183251815A5021431857 @default.
• W2183251815 hasAuthorship W2183251815A5043410223 @default.
• W2183251815 hasAuthorship W2183251815A5050134509 @default.
• W2183251815 hasAuthorship W2183251815A5052118706 @default.
• W2183251815 hasAuthorship W2183251815A5086321001 @default.
• W2183251815 hasBestOaLocation W21832518151 @default.
• W2183251815 hasConcept C126322002 @default.
• W2183251815 hasConcept C127413603 @default.
• W2183251815 hasConcept C144024400 @default.
• W2183251815 hasConcept C144133560 @default.
• W2183251815 hasConcept C162853370 @default.
• W2183251815 hasConcept C17744445 @default.
• W2183251815 hasConcept C177713679 @default.
• W2183251815 hasConcept C1862650 @default.
• W2183251815 hasConcept C190248442 @default.
• W2183251815 hasConcept C199539241 @default.
• W2183251815 hasConcept C2776301958 @default.
• W2183251815 hasConcept C2779161974 @default.
• W2183251815 hasConcept C2779473830 @default.
• W2183251815 hasConcept C2780645631 @default.
• W2183251815 hasConcept C3018553135 @default.
• W2183251815 hasConcept C36289849 @default.
• W2183251815 hasConcept C512399662 @default.
• W2183251815 hasConcept C56995899 @default.
• W2183251815 hasConcept C71924100 @default.
• W2183251815 hasConcept C78519656 @default.
• W2183251815 hasConceptScore W2183251815C126322002 @default.
• W2183251815 hasConceptScore W2183251815C127413603 @default.
• W2183251815 hasConceptScore W2183251815C144024400 @default.
• W2183251815 hasConceptScore W2183251815C144133560 @default.
• W2183251815 hasConceptScore W2183251815C162853370 @default.
• W2183251815 hasConceptScore W2183251815C17744445 @default.
• W2183251815 hasConceptScore W2183251815C177713679 @default.
• W2183251815 hasConceptScore W2183251815C1862650 @default.
• W2183251815 hasConceptScore W2183251815C190248442 @default.
• W2183251815 hasConceptScore W2183251815C199539241 @default.
• W2183251815 hasConceptScore W2183251815C2776301958 @default.
• W2183251815 hasConceptScore W2183251815C2779161974 @default.
• W2183251815 hasConceptScore W2183251815C2779473830 @default.
• W2183251815 hasConceptScore W2183251815C2780645631 @default.
• W2183251815 hasConceptScore W2183251815C3018553135 @default.
• W2183251815 hasConceptScore W2183251815C36289849 @default.
• W2183251815 hasConceptScore W2183251815C512399662 @default.
• W2183251815 hasConceptScore W2183251815C56995899 @default.
• W2183251815 hasConceptScore W2183251815C71924100 @default.
• W2183251815 hasConceptScore W2183251815C78519656 @default.
• W2183251815 hasIssue "5" @default.
• W2183251815 hasLocation W21832518151 @default.
• W2183251815 hasLocation W21832518152 @default.
• W2183251815 hasOpenAccess W2183251815 @default.
• W2183251815 hasPrimaryLocation W21832518151 @default.
• W2183251815 hasRelatedWork W1983415041 @default.
• W2183251815 hasRelatedWork W2003235938 @default.
• W2183251815 hasRelatedWork W2081145557 @default.
• W2183251815 hasRelatedWork W2114223015 @default.
• W2183251815 hasRelatedWork W2157689025 @default.
• W2183251815 hasRelatedWork W2274835053 @default.
• W2183251815 hasRelatedWork W2415605004 @default.
• W2183251815 hasRelatedWork W2460869168 @default.

• next